Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
John Brooks
AddedMar 31, 2024
UpdatedMay 31, 2026
John Brooks

John Brooks

Board Member, Pittsburgh Life Sciences Greenhouse

CrunchbaseLinkedIn

John Brooks's Career

Pittsburgh Life Sciences Greenhouse
Pittsburgh Life Sciences Greenhouse

Pittsburgh, PA, US

Board Member· Board
iSpecimen
iSpecimen

Lexington, MA, US

Board Member· Board
Noxilizer
Noxilizer

Baltimore, MD, US

Board Member· Board
Hygieia
Hygieia

Ann Arbor, MI, US

Board Member· Board
Atentiv
Atentiv

Waltham, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

John Brooks's Career

Pittsburgh Life Sciences Greenhouse
Pittsburgh Life Sciences Greenhouse
Investment FirmInvestment Firm362001Pittsburgh, PA, US
Board Member· Board

Leadership at Pittsburgh Life Sciences Greenhouse

Dennis YablonskyDennis YablonskyBoard Member
John KuzmishinJohn KuzmishinBoard Member
Pete DecomoPete DecomoBoard Member
Jim JordanJim JordanBoard Member
Timothy McNulty \"Tim\"Timothy McNulty \"Tim\"Board Member
MICHAEL DUARTEMICHAEL DUARTEBoard Member
iSpecimen
iSpecimen
Public$31M752009Lexington, MA, US
Board Member· Board

Leadership at iSpecimen

Jill MullanJill MullanBoard Member
Tracy Wilson CurleyTracy Wilson CurleyCEO
Christopher IanelliChristopher IanelliFounder
Catriona MartinCatriona MartinBoard Member
Joseph J. BasileJoseph J. BasileBoard Member
Andrew RossAndrew RossBoard Member

Similar to iSpecimen

LabscoopLabscoopLittle Rock, AR, USScientific Suppliesest. 2014LabscoopLittle Rock, AR, US · est. 2014

Labscoop: A global science eCommerce platform optimizing lab ordering through a vast scientific marketplace.

Seed · $1.2M30
VivebioVivebioLawrenceville, GA, USBiological Specimen Storageest. 2009VivebioLawrenceville, GA, US · est. 2009

Vivebio: Innovative biotech firm specializing in cost-effective biological specimen storage & transport.

Series A · $3.7M30
Noxilizer
Noxilizer
Private Equity$4.4M162004Baltimore, MD, US
Board Member· Board

Leadership at Noxilizer

Kyle SalyersKyle SalyersBoard Member
Jerry ParrottJerry ParrottBoard Member
Lars HananLars HananBoard Member
Marie-Louise MurvilleMarie-Louise MurvilleFounder
Lawrence BruderLawrence BruderBoard Member
Jerry ParrottJerry ParrottBoard Member
Hygieia
Hygieia

Ann Arbor, MI, US

Board Member· Board
Atentiv
Atentiv
Seed$11.2M112012Waltham, MA, US
Board Member· Board

Leadership at Atentiv

Eric GordonEric GordonBoard Member

Similar to Atentiv

MentavaMentavaTacoma, WA, USEducational Softwareest. 2021MentavaTacoma, WA, US · est. 2021

Mentava: A leading software company empowering top-performing students to reach their potential.

Seed · $3M4
Attention PointAttention PointRoanoke, VA, USADHD Assessment, Behavioral Healthest. 2012Attention PointRoanoke, VA, US · est. 2012

Health IT firm, Attention Point, provides web-based tools for behavioral health diagnosis, specializing in ADHD assessment.

Seed · $25k30
TeachTownTeachTownWoburn, MA, USEducational Softwareest. 2003TeachTownWoburn, MA, US · est. 2003

TeachTown, based in Woburn, US, offers specialized educational software for children with developmental disorders.

Private Equity · $5.6M115
AttentionAttentionNew York City, NY, USSales Softwareest. 2021AttentionNew York City, NY, US · est. 2021

NYC-based Attention offers AI-powered sales tools for real-time coaching, CRM auto-fill, and intelligent follow-ups, boosting revenue and efficiency.

Seed · $3.1M17

John Brooks's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to John Brooks

Geoffrey CrouseGeoffrey CrouseBoard Member · InvitaeWilliam WilsonWilliam WilsonBoard Member · DropsourceMark LaretMark LaretBoard Member · RegardShaun AndrikopoulosShaun AndrikopoulosFounder · Teton Sports & Spine ImagingBrad WebbBrad WebbBoard Member · NuMediiJeff McLarenJeff McLarenBoard Member · HealthStream